Skip to main content

Table 1 Clinical and demographic variables at ICU admission

From: Eosinophil count at intensive care unit admission was not predictor of hospital mortality: results of a case control study

Variable

Total

Survivors

Non-survivors

P value

Patients

185 (100.0)

99 (53.5)

86 (46.5)

 

Age, years

47 (18.2)

43 (17.4)

51 (18.3)

0.003

Men

128 (69.2)

74 (74.7)

54 (62.8)

0.079

APACHE II, score

16 (1–37)

12 (1–30)

21 (9–37)

<0.001

SOFA, score

6 (0–20)

5 (0–14)

9 (2–20)

<0.001

Predicted mortality, %

25 (4–85)

15 (4–75)

40 (9–85)

<0.001

Comorbidities

    

 DM2

58 (31.4)

23 (23.2)

35 (40.7)

0.011

 Ischemic cardiopathy

24 (13.0)

12 (12.1)

12 (14.0)

0.711

 Chronic nephropathy

23 (12.4)

5 (5.1)

18 (20.9)

0.001

 Chronic liver disease

7 (3.8)

2 (2.0)

5 (5.8)

0.265

 Chronic pneumopathy

7 (3.8)

4 (4.0)

3 (3.5)

1.000

 Blood neoplasia

1 (0.5)

1 (1.0)

0 (0.0)

1.000

 Solid neoplasia

15 (8.1)

4 (4.4)

11 (12.8)

0.030

 HIV infection

5 (2.7)

1 (1.0)

4 (4.7)

0.285

ICU admission diagnosis

    

 Medical

87 (47.0)

37 (37.4)

50 (58.1)

0.005

 Surgical, urgent

40 (21.6)

19 (19.2)

21 (24.4)

0.389

 Surgical, elective

25 (13.5)

21 (21.2)

4 (4.7)

0.001

 Trauma

33 (17.8)

22 (22.2)

11 (12.8)

0.095

 ICU admission eosinophils count, K/μL

0.013 (0.0–0.578)

0.014 (0.0–0.363)

0.010 (0.0–0.578)

0.355

 Hospital stay, days

14 (2–96)

18 (3–96)

11.5 (2–56)

0.007

 ICU stay, days

6 (1–46)

5 (1–28)

7.5 (1–46)

0.004

  1. Data are shown as number and percentage, mean and standard deviation or median and interquartile range as needed
  2. ICU intensive care unit, APACHE II acute physiology and chronic health evaluation II, SOFA sequential organ failure assessment score, DM2 type 2 diabetes mellitus, HIV human immunodeficiency virus